8-Bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione is a chemical intermediate employed to synthesize selective inhibitors of dipeptidyl peptidase 4 (DPP4), with potential application in treating type 2 diabetes.
8-Bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
| API Name | Linagliptin |
|---|---|
| CAS No | 853029-57-9 |
| Molecular Formula | C20H17BrN6O2 |
| Molecular Weight | 453.3 g/mol |
| Synonyms | 8-bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione |
Zoho Contact Form
"*" indicates required fields